newsfilter
← Latest News
Business Wire·

Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations

Collaboration goal to develop alternative methods to assess clinical performance of product variants under different conditions Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus"), a leading provider of